Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
TerminatedNCT03351244
Efficacy, Safety, and Tolerability of Orally Administered BI 409306 During a 28-week Treatment Period for schizophrenia
This study was terminated in the United States, in France, in Canada, .... It is testing Efficacy, Safety, and Tolerability of Orally Administered BI 409306 During a 28-week Treatment Period for schizophrenia.
SchizophreniaDrugFrom 18 Years to 55 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: December 7, 2017
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 264
- Sponsor
- Boehringer Ingelheim
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, France, Canada, ...
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT03351244
- Official title
- A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Orally Administered BI 409306 During a 28-week Treatment Period as Adjunctive Therapy to Antipsychotic Treatment for the Prevention of Relapse in Patients With Schizophrenia.
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT03351244. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Canada · 6 sites
- University of CalgaryCalgary, AlbertaSite status: Not listed — confirm with the team
- Dr. Alexander McIntyre Inc.Penticton, British ColumbiaSite status: Not listed — confirm with the team
- The Medical Arts Health Research GroupVancouver, British ColumbiaSite status: Not listed — confirm with the team
- Chatham-Kent Clinical Trials Research CentreChatham, OntarioSite status: Not listed — confirm with the team
- Centre for Addiction and Mental Health (CAMH)Toronto, OntarioSite status: Not listed — confirm with the team
- IUSMM Institut Universitaire en Sante Mentale de MontrealMontreal, QuebecSite status: Not listed — confirm with the team
France · 5 sites
- HOP la ColombièreMontpellierSite status: Not listed — confirm with the team
- GHU Paris Psychiatrie et NeurosciencesParisSite status: Not listed — confirm with the team
- HOP Guillaume RégnierRennesSite status: Not listed — confirm with the team
- HOP NordSaint-Priest-en-JarezSite status: Not listed — confirm with the team
- HOP Sainte MusseToulonSite status: Not listed — confirm with the team
Japan · 10 sites
- Okehazama Hospital Fujita Kokoro Care CenterAichi, ToyoakeSite status: Not listed — confirm with the team
- Fujita Health University HospitalAichi, ToyoakeSite status: Not listed — confirm with the team
- National Center for Global Health and Medicine Kohnodai HospitalChiba, IchikawaSite status: Not listed — confirm with the team
- Fukuoka University HospitalFukuoka, FukuokaSite status: Not listed — confirm with the team
- Kuramitsu HospitalFukuoka, FukuokaSite status: Not listed — confirm with the team
- Soushu HospitalKanagawa, AtsugiSite status: Not listed — confirm with the team
- Kishiro Mental ClinicKanagawa, KawasakiSite status: Not listed — confirm with the team
- Nara Medical University HospitalNara, KashiharaSite status: Not listed — confirm with the team
- National Hospital Organization Hizen Psychiatric Medical CenterSaga, Kanzaki-gunSite status: Not listed — confirm with the team
- National Center Neurology and PsychiatryTokyo, KodairaSite status: Not listed — confirm with the team
South Korea · 3 sites
- Chonnam National University HospitalGwangjuSite status: Not listed — confirm with the team
- Seoul National University Bundang HospitalSeongnamSite status: Not listed — confirm with the team
- Seoul National University HospitalSeoulSite status: Not listed — confirm with the team
Spain · 1 site
- Hospital Universitario Marqués de ValdecillaSantanderSite status: Not listed — confirm with the team
Taiwan · 2 sites
- NCKUHTainanSite status: Not listed — confirm with the team
- Taoyuan Psychiatric CenterTaoyuanSite status: Not listed — confirm with the team
United States · 32 sites
- Alea ResearchPhoenix, ArizonaSite status: Not listed — confirm with the team
- ATP Clinical Research, Inc.Costa Mesa, CaliforniaSite status: Not listed — confirm with the team
- Collaborative Neuroscience Network, LLC (CNS)Garden Grove, CaliforniaSite status: Not listed — confirm with the team
- Behavioral Research Specialists, LLCGlendale, CaliforniaSite status: Not listed — confirm with the team
- Synergy EastLemon Grove, CaliforniaSite status: Not listed — confirm with the team
- University of California Los AngelesLos Angeles, CaliforniaSite status: Not listed — confirm with the team
- Excell Research Inc.Oceanside, CaliforniaSite status: Not listed — confirm with the team
- Orange County Neuropsychiatric Research Center LLCOrange, CaliforniaSite status: Not listed — confirm with the team
- Collaborative Neuroscience Network, LLC (CNS)Torrance, CaliforniaSite status: Not listed — confirm with the team
- MD ClinicalHallandale, FloridaSite status: Not listed — confirm with the team
- Reliable Clinical ResearchHialeah, FloridaSite status: Not listed — confirm with the team
- Meridien ResearchMaitland, FloridaSite status: Not listed — confirm with the team
- Behavioral Clinical Research, Inc.North Miami, FloridaSite status: Not listed — confirm with the team
- Meridien ResearchOrlando, FloridaSite status: Not listed — confirm with the team
- Atlanta CenterAtlanta, GeorgiaSite status: Not listed — confirm with the team
- Alam Medical Research, Inc.Chicago, IllinoisSite status: Not listed — confirm with the team
- Lake Charles Clinical Trials LLCLake Charles, LouisianaSite status: Not listed — confirm with the team
- Clinical Trials of America, LLCMonroe, LouisianaSite status: Not listed — confirm with the team
- Michigan Clinical Research Institute PCAnn Arbor, MichiganSite status: Not listed — confirm with the team
- Precise Research CentersFlowood, MississippiSite status: Not listed — confirm with the team
- St. Charles Psychiatric Associates & Midwest Research GroupSaint Charles, MissouriSite status: Not listed — confirm with the team
- Arch Clinical TrialsSt Louis, MissouriSite status: Not listed — confirm with the team
- PsychCare Consultants ResearchSt Louis, MissouriSite status: Not listed — confirm with the team
- Altea Research InstituteLas Vegas, NevadaSite status: Not listed — confirm with the team
- Hassman Research InstituteBerlin, New JerseySite status: Not listed — confirm with the team
- Neurobehavioral Research, Inc.Cedarhurst, New YorkSite status: Not listed — confirm with the team
- New York State Psychiatric InstituteNew York, New YorkSite status: Not listed — confirm with the team
- Manhattan Behavioral Medicine PLLCNew York, New YorkSite status: Not listed — confirm with the team
- Community Clinical Research, Inc.Austin, TexasSite status: Not listed — confirm with the team
- University Hills Clinical ResearchIrving, TexasSite status: Not listed — confirm with the team
- Pillar Clinical Research, LLCRichardson, TexasSite status: Not listed — confirm with the team
- @Health TexasRichmond, TexasSite status: Not listed — confirm with the team
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving BI 409306, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 55 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Boehringer Ingelheim, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
TerminatedNCT01568216
20101299: Study Effect of AMG 747 on Schizophrenia Negative Symptoms
This study was terminated in the United States, in Australia, in Canada, .... It focuses on schizophrenia.
TerminatedNCT01568229
20110165: Study Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)
This study was terminated in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.
TerminatedNCT00946985
28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years
This study was terminated in the United States, in Canada, in Brazil, .... It focuses on schizophrenia.